This website requires JavaScript.
DOI: 10.1101/2023.03.16.23287333

Real-world effectiveness of mpox (monkeypox) vaccines: a systematic review

M.Xu C. Liu Z. Du Y. Bai Z. Wang C. Gao
摘要
Understanding the effectiveness of smallpox vaccines against mpox in humans can inform public health preparedness for mpox prophylaxis during the 2022 outbreak. However, the efficacy of current vaccines against mpox has been inferred from animal and immunogenicity studies and has barely been demonstrated in human clinical trials. Thus, we conducted a systematic literature review to estimate the real-world effectiveness of mpox vaccines. The study showed a pooled estimate of 0.89 (95% CI: 0.86-0.91) for the third-generation smallpox vaccine (MVA-BN) effectiveness during the 2022 outbreak. The results showed that the incidence of mpox was significantly lower in the vaccinated group than in the unvaccinated group. Considering the potential mutations, side effects, and breakthrough infections, it is recommended to develop a next-generation vaccine that is more effective and safer for future mpox outbreaks.
展开全部
图表提取

暂无人提供速读十问回答

论文十问由沈向洋博士提出，鼓励大家带着这十个问题去阅读论文，用有用的信息构建认知模型。写出自己的十问回答，还有机会在当前页面展示哦。

Q1论文试图解决什么问题？
Q2这是否是一个新的问题？
Q3这篇文章要验证一个什么科学假设？
0
被引用
0
笔记
0
问答